China’s humanoid robots stunned millions at the CCTV Spring Festival Gala, showcasing rapid AI advances, industrial ambition, and rising global competition.

Overview Pandas continues to be a core Python skill in 2026, powering data analysis, cleaning, and engineering workflows ...

Coforge Limited (NSE: COFORGE), a global digital services and solutions provider, today announced expanded new capabilities for Coforge CodeInsightAI, its agentic AI-powered code intelligence and ...

Vladimir Zakharov explains how DataFrames serve as a vital tool for data-oriented programming in the Java ecosystem. By ...

Data centers have caused the demand for gas-fired power in the US to explode over the past two years, according to new research released Wednesday. More than a third of this new demand, the research ...

After Las Vegas CES ElephantSqlDB® Opens $46M Pre-IPO Round Following $143M Enterprise Pipeline NVIDIA Inception Partner Reports $143M in Active POCs Following August Platform Launch; Targets NASDAQ ...

Hyatt Hotels Corporation is entering 2026 with high expectations on the heels of a banner 2025. The Chicago-based hotel company finished 2025 with its highest number of U.S. room signings in five ...

Ha Nguyen McNeill, senior official performing the duties of the administrator of the Transportation Security Administration, testifies during the DHS oversight hearing in the Cannon House office ...

(Alliance News) - GSK PLC on Tuesday announced the USD2.2 billion acquisition of RAPT Therapeutics Inc, a California-based clinical-stage biopharmaceutical company focused on novel therapies for ...

Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY) today announced strong preliminary, unaudited net product revenue for Q4 and full year 2025 of approximately $243 million and $868 million, ...

Meta has cut a trio of deals to power its artificial intelligence data centers, securing enough energy to light up the equivalent of about 5 million homes. The parent company of Facebook on Friday ...

Eli Lilly is building its prospects in immunology through the $1.2 billion acquisition of Ventyx Biosciences, a clinical-stage company with drugs addressing a promising target offering the potential ...